Not sure @Parlay . When they get enough positive safety data to secure ethics clearance they will no doubt move to clinical trials. Each milestone achieved should see a re-rate IMO.
Ann: Top 20 Holders, page-77
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.93 |
Change
0.040(2.12%) |
Mkt cap ! $174.4M | |||
| Open | High | Low | Value | Volume |
| $1.91 | $1.95 | $1.91 | $140.5K | 72.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2067 | $1.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.93 | 4701 | 1 |
View Market Depth
| Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
| EMV (ASX) Chart |
